Journal
DRUG DISCOVERY TODAY
Volume 8, Issue 2, Pages 86-96Publisher
ELSEVIER SCI LTD
DOI: 10.1016/S1359644602025722
Keywords
-
Categories
Ask authors/readers for more resources
Biochemical assays have largely supplanted functional biological assays as drug screening tools in the early stages of drug discovery. The de-selection of compounds that are 'nonleadlike' binders (and bonders) and the proactive selection of those compounds that are 'leadlike' in their binding to the target are vital components of the screening effort. The physiochemical properties of leadlikeness and the surprising differences between those properties and the now classical definitions of druglikeness are becoming apparent.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available